MARIA ELENA
PADIN IRUEGAS
PROFESOR/A CONTRATADO/A DOUTOR/A A T.C.
![Foto de MARIA ELENA](/img/nophoto.png)
![Foto de Complexo Hospitalario Universitario de Santiago](/img/noimage_org.png)
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (18)
2024
-
Genetic linkage analysis of head and neck cancer in a Spanish family
Oral Diseases, Vol. 30, Núm. 3, pp. 1032-1039
2021
-
Immunoexpression of Apoptosis and Cell-cycle Arrest Markers in Oral Lichen Planus
Applied immunohistochemistry & molecular morphology : AIMM, Vol. 29, Núm. 5, pp. 374-381
-
Immunohistochemical Characterization of Bcl-2 in Oral Potentially Malignant Disorders
Applied Immunohistochemistry and Molecular Morphology, Vol. 29, Núm. 9, pp. 706-712
2020
-
Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population
ecancermedicalscience, Vol. 14
2019
-
Comprehensive genomic review of TCGA head and neck squamous cell carcinomas (HNSCC)
Journal of Clinical Medicine, Vol. 8, Núm. 11
-
miRNAs expression of oral squamous cell carcinoma patients: Validation of two putative biomarkers
Medicine, Vol. 98, Núm. 13, pp. e14922
2018
-
Dental management prior to radiation therapy in patients with head and neck cancer
Indian Journal of Cancer, Vol. 55, Núm. 3, pp. 251-256
-
Quality variations of extractable RNA in frozen samples of oral cancer (21 y); optimization of the extraction protocol
Biomedical Research (India), Vol. 29, Núm. 12, pp. 2522-2527
-
State of methylation and epigenome studies in some types of head and neck cancer
Biomedical Research (India), Vol. 29, Núm. 14, pp. 2944-2955
2016
-
Comparison of rna extraction methods for molecular analysis of oral cytology
Acta Stomatologica Croatica, Vol. 50, Núm. 2, pp. 108-115
-
HIN-1: a New Epigenetic Biomarker Crucial for Therapy Selection in Glioblastoma Multiforme
Molecular Neurobiology, Vol. 53, Núm. 3, pp. 1802-1807
2015
-
Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction
Clinical and Translational Oncology, Vol. 17, Núm. 11, pp. 856-861
-
P21Waf1/CIP1 is a poor diagnostic and prognostic marker for OSCC although its expression increases in patients with N1 regional metastasis
Cancer Biomarkers, Vol. 15, Núm. 1, pp. 19-26
2014
-
CA15.3 serum concentrations in older women with infiltrating ductal carcinomas of the breast
International Journal of Molecular Sciences, Vol. 15, Núm. 11, pp. 19870-19876
-
Pancreatic ductal adenocarcinoma: Implications of epigenetic role related the src pathway
Journal of Cancer Science and Therapy, Vol. 6, Núm. 2, pp. 045-051
-
Quantitative determination of c-myc facilitates the assessment of prognosis of OSCC patients
Oncology Reports, Vol. 31, Núm. 4, pp. 1677-1682
2013
-
Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer
Oncology Reports, Vol. 29, Núm. 6, pp. 2467-2472
2012
-
Stem cells as a tool for breast imaging
Journal of Oncology